Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma

Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma

Abstract Background Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths worldwide every year, and most HCC patients are diagnosed with advanced disease and can only receive systemic treatment. TKIs are the most important components of the systemic treatment of HCC and...

Full description

Bibliographic Details
Main Authors: Xiaoying Gu, Su Zhang, Xuejiao Yang, Tao Guan, Zhenyu Hou, Manqing Cao, Huikai Li, Ti Zhang
Format: Article
Language:English
Published: BMC 2022-10-01
Series:BMC Gastroenterology
Subjects:
Apatinib
Anti-angiogenesis therapy
Adverse Events
Hepatocellular Carcinoma
Prognosis
Online Access:https://doi.org/10.1186/s12876-022-02542-0

Similar Items

Similar Items